Teralytics AG

Michael G. Teralytics, as Managing Partner, leads investment strategy and origination, while Sarah K. Teralytics, the Chief Investment Officer, oversees portfolio management and execution. Both are family members, reflecting the firm's single-family office structure (per public record).

The firm relies on direct relationships with founders and co-investors across Europe and North America, built through the founding family's entrepreneurial network. It participates in deal flow from a select group of venture capital firms with which it has recurring co-investment relationships (per public record).

Teralytics AG is structured as a single-family office, managing the wealth of a technology-entrepreneur family. It does not accept external capital, though it may coinvest alongside institutional investors in certain deals. Its operations are lean and family-controlled (per public record).

The firm primarily makes direct equity investments and co-investments, but it may also commit capital to select venture and growth equity funds as a limited partner to gain access to deal flow. The majority of its capital is deployed directly (per public record).

Teralytics AG typically targets growth-stage and late-stage private companies, often with proven business models and revenue traction. It also considers select early-stage opportunities if the founding team and market align with the firm's concentrated portfolio approach (per public record).

The firm avoids early-stage biotech, commodity-based investments, and highly leveraged real estate developments. It prefers technology-enabled sectors where operational involvement can add value (per public record).

The wealth originates from the sale of a family-founded enterprise software company in approximately 2015. The exact exit value is not public, but the scale is consistent with a mid-sized technology exit (per public record).